BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34487839)

  • 21. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
    Sergio Tde O; Spiacci A; Zangrossi H
    Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
    Batista PA; Fogaça MV; Guimarães FS
    Behav Brain Res; 2015 Oct; 293():182-8. PubMed ID: 26187694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organization of electrically and chemically evoked defensive behaviors within the deeper collicular layers as compared to the periaqueductal gray matter of the rat.
    Bittencourt AS; Nakamura-Palacios EM; Mauad H; Tufik S; Schenberg LC
    Neuroscience; 2005; 133(4):873-92. PubMed ID: 15916856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRF type 1 receptors in the dorsal periaqueductal gray modulate anxiety-induced defensive behaviors.
    Litvin Y; Pentkowski NS; Blanchard DC; Blanchard RJ
    Horm Behav; 2007 Aug; 52(2):244-51. PubMed ID: 17540371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson's disease rat model.
    Fatemi I; Abdollahi A; Shamsizadeh A; Allahtavakoli M; Roohbakhsh A
    Acta Neuropsychiatr; 2021 Feb; 33(1):15-21. PubMed ID: 32967746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin B receptors in the periaqueductal gray potentiate defensive rage behavior elicited from the medial hypothalamus of the cat.
    Luo B; Cheu JW; Siegel A
    Brain Res; 1998 Jun; 796(1-2):27-37. PubMed ID: 9689451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance.
    De Souza MM; Schenberg LC; de Pádua Carobrez A
    Behav Brain Res; 1998 Feb; 90(2):157-65. PubMed ID: 9521547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of glutamate NMDA receptors and nitric oxide located within the periaqueductal gray on defensive behaviors in mice confronted by predator.
    Carvalho-Netto EF; Gomes KS; Amaral VC; Nunes-de-Souza RL
    Psychopharmacology (Berl); 2009 Jul; 204(4):617-25. PubMed ID: 19241059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restricted lesions of the ventrolateral or dorsal columns of the periaqueductal gray promotes distinct effects on tonic immobility and defensive analgesia in guinea pigs.
    Vieira-Rasteli EB; de Paula BB; de Paiva YB; Coimbra NC; Leite-Panissi CRA
    Physiol Behav; 2018 Oct; 194():538-544. PubMed ID: 30003893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPR30 receptor promotes preoperative anxiety-induced postoperative hyperalgesia by up-regulating GABA
    Jiang M; Sun Y; Lei Y; Hu F; Xia Z; Liu Y; Ma Z; Gu X
    BMC Anesthesiol; 2020 Apr; 20(1):93. PubMed ID: 32321426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats.
    Pelosi GG; Resstel LL; Soares VP; Zangrossi H; Guimarães FS; Corrêa FM
    Behav Pharmacol; 2009 May; 20(3):252-9. PubMed ID: 19407657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats.
    Rahimi A; Hajizadeh Moghaddam A; Roohbakhsh A
    Fundam Clin Pharmacol; 2015 Apr; 29(2):185-90. PubMed ID: 25620584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of opioid and GABA systems in the ventrolateral periaqueductal gray on analgesia associated with tonic immobility.
    Miranda-Páez A; Zamudio S; Vázquez-León P; Campos-Rodríguez C; Ramírez-San Juan E
    Pharmacol Biochem Behav; 2016 Mar; 142():72-8. PubMed ID: 26780595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
    Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
    Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amygdala Arginine Vasopressin Modulates Chronic Ethanol Withdrawal Anxiety-Like Behavior in the Social Interaction Task.
    Harper KM; Knapp DJ; Butler RK; Cook CA; Criswell HE; Stuber GD; Breese GR
    Alcohol Clin Exp Res; 2019 Oct; 43(10):2134-2143. PubMed ID: 31386210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation.
    Back FP; Carobrez AP
    Neuropharmacology; 2018 Jun; 135():399-411. PubMed ID: 29596901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of melatonin injection into the periaqueductal gray on antinociception and tonic immobility in male rats.
    Miranda-Páez A; Zamudio SR; Vázquez-León P; Sandoval-Herrera V; Villanueva-Becerril I; Carli G
    Horm Behav; 2017 Mar; 89():23-29. PubMed ID: 27988316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
    Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
    Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.